Skin cancers in organ transplant recipients

Long‐term utilization of immunosuppression in organ transplant recipients (OTRs) leads to decreased immune‐mediated tumour surveillance and development of malignant tumours a delicate balance needs to be maintained in the intensity of immunosuppression to keep the risk of malignancy low without jeopardizing life‐saving graft function. OTRs are prone to developing skin cancers that exhibit unique epidemiologic, pathophysiologic, and prognostic characteristics

  • Squamous Cell Carcinoma
  • Skin cancer screening
  • Pathogenesis
  • Actinic Keratoses
  • Systemic chemoprophylaxis
  • Staging of cutaneous SCCs
  • Metastatic Cutaneous SCC
  • Kaposi Sarcoma
  • Merkel Cell Carcinoma
  • Rare Cutaneous Tumours

Related Conference of Skin cancers in organ transplant recipients

February 05-06, 2026

9th Annual Conference on Skin Cancer and Dermatology

Paris, France
April 16-17, 2026

9th World Cosmetic and Dermatology Congress

Paris, France
June 15-16, 2026

COSMETIC DERMATOLOGY 2026

Paris, France
June 22-23, 2026

28th World Dermatology and Aesthetic Congress

London, UK
June 25-26, 2026

27th World Dermatology Congress

Paris, France
July 20-21, 2026

20th International Conference on Alzheimers Disease & Dementia

Amsterdam, Netherlands
August 25-26, 2026

26th European Dermatology Congress

Paris, France

Skin cancers in organ transplant recipients Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in